NCT01757470View on ClinicalTrials.gov

Vandetanib Risk Minimisation Effectiveness

CompletedOBSERVATIONAL

Enrollment

12

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Medullary Thyroid Cancer

Trial Locations (1)

Unknown

Research Site, Montreal

All Listed Sponsors

lead

Genzyme, a Sanofi Company

INDUSTRY

NCT01757470 - Vandetanib Risk Minimisation Effectiveness | Biotech Hunter | Biotech Hunter